These characteristics determine that NPC is may benefit from immune checkpoint blockade, which blocks immune checkpoint interactions like programmed death receptor-1 (PD-1) and its ligand PD-L1 to cut off immunosuppressive signals from tumor cells and reverse T cell exhaustion [16]. This evidence concerns the gene PDCD1 and nasopharyngeal carcinoma.